Healthcare provider profile · identity verified

Shane Daniel Newhouser, D.O.

Family Practice · STATE COLLEGE, PA · NPI 1407175219

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	670	189
Lisinopril	Lisinopril	441	127
Amlodipine Besylate	Amlodipine Besylate	428	116
Levothyroxine Sodium	Levothyroxine Sodium	420	102
Rosuvastatin Calcium	Rosuvastatin Calcium	338	97
Omeprazole	Omeprazole	334	91
Gabapentin	Gabapentin	294	66
Metoprolol Succinate	Metoprolol Succinate	282	74
Hydrochlorothiazide	Hydrochlorothiazide	218	58
Losartan Potassium	Losartan Potassium	206	64
Lorazepam	Lorazepam	182	44
Eliquis	Apixaban	179	35
Escitalopram Oxalate	Escitalopram Oxalate	175	40
Furosemide	Furosemide	170	46
Pantoprazole Sodium	Pantoprazole Sodium	158	46
Tamsulosin Hcl	Tamsulosin Hcl	155	46
Warfarin Sodium	Warfarin Sodium	151	30
Metformin Hcl Er	Metformin Hcl	150	42
Duloxetine Hcl	Duloxetine Hcl	144	29
Metformin Hcl	Metformin Hcl	126	35
Trazodone Hcl	Trazodone Hcl	121	34
Fluticasone Propionate	Fluticasone Propionate	118	39
Buspirone Hcl	Buspirone Hcl	115	24
Albuterol Sulfate Hfa	Albuterol Sulfate	107	40
Montelukast Sodium	Montelukast Sodium	105	29
Ozempic	Semaglutide	105	20
Famotidine	Famotidine	104	28
Meloxicam	Meloxicam	104	25
Tramadol Hcl	Tramadol Hcl	101	27
Alendronate Sodium	Alendronate Sodium	97	29
Atenolol	Atenolol	97	32
Jardiance	Empagliflozin	97	22
Allopurinol	Allopurinol	93	28
Oxycodone Hcl	Oxycodone Hcl	93	19
Simvastatin	Simvastatin	93	28
Metoprolol Tartrate	Metoprolol Tartrate	78	27
Alprazolam	Alprazolam	77	21
Citalopram Hbr	Citalopram Hydrobromide	75	18
Prednisone	Prednisone	73	50
Sertraline Hcl	Sertraline Hcl	71	20
Clopidogrel	Clopidogrel Bisulfate	70	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	70	22
Tizanidine Hcl	Tizanidine Hcl	69	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	68	18
Finasteride	Finasteride	65	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	62	15
Zolpidem Tartrate	Zolpidem Tartrate	62	18
Glipizide Er	Glipizide	61	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	20
Fluoxetine Hcl	Fluoxetine Hcl	60	14
Pravastatin Sodium	Pravastatin Sodium	60	16
Spironolactone	Spironolactone	58	20
Ezetimibe	Ezetimibe	54	18
Bupropion Xl	Bupropion Hcl	53	16
Diclofenac Sodium	Diclofenac Sodium	53	18
Potassium Chloride	Potassium Chloride	53	17
Synthroid	Levothyroxine Sodium	52	15
Triamcinolone Acetonide	Triamcinolone Acetonide	51	25
Carvedilol	Carvedilol	48	11
Amitriptyline Hcl	Amitriptyline Hcl	47	15
Mirtazapine	Mirtazapine	45	14
Pregabalin	Pregabalin	45	13
Doxycycline Hyclate	Doxycycline Hyclate	43	30
Azithromycin	Azithromycin	42	33
Ropinirole Hcl	Ropinirole Hcl	40	12
Valacyclovir	Valacyclovir Hcl	40	23
Clonazepam	Clonazepam	37	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	suppressed
Myrbetriq	Mirabegron	33	suppressed
Glipizide	Glipizide	32	suppressed
Bupropion Hcl Sr	Bupropion Hcl	30	suppressed
Memantine Hcl	Memantine Hcl	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Ketoconazole	Ketoconazole	28	16
Ondansetron Hcl	Ondansetron Hcl	28	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	27
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	27	27
Ondansetron Odt	Ondansetron	27	11
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Diazepam	Diazepam	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Novolog Flexpen	Insulin Aspart	25	suppressed
Meclizine Hcl	Meclizine Hcl	24	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	21
Benazepril Hcl	Benazepril Hcl	23	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	23	23
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	22	22
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Rizatriptan	Rizatriptan Benzoate	22	suppressed
Glimepiride	Glimepiride	21	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Linzess	Linaclotide	20	suppressed
Sotalol	Sotalol Hcl	20	suppressed
Amoxicillin	Amoxicillin	19	12
Celecoxib	Celecoxib	19	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	19	suppressed
Oxycontin	Oxycodone Hcl	19	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	19	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Klor-Con M20	Potassium Chloride	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Terazosin Hcl	Terazosin Hcl	17	suppressed
Baclofen	Baclofen	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	15	suppressed
Jantoven	Warfarin Sodium	15	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Cephalexin	Cephalexin	14	11
Labetalol Hcl	Labetalol Hcl	14	suppressed
Lubiprostone	Lubiprostone	14	suppressed
Lyrica	Pregabalin	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Naproxen	Naproxen	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Torsemide	Torsemide	13	suppressed
Unifine Pentips	Pen Needle, Diabetic	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Valsartan	Valsartan	12	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Nystatin	Nystatin	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Sulindac	Sulindac	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error